Skip to main content
Log in

Price of Harvoni "unsustainable", says AHF

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. AIDS Drugs Assistance Programs

Reference

  • AIDS Healthcare Foundation. AHF Hammers Gilead on Unsustainable $94.5K Price of New Hepatitis C Drug, Harvoni. Media Release : 10 Oct 2014. Available from: URL: http://www.aidshealth.org

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Price of Harvoni "unsustainable", says AHF. PharmacoEcon Outcomes News 714, 5 (2014). https://doi.org/10.1007/s40274-014-1626-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1626-0

Navigation